Citadel Advisors - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is and the CUSIP is 14161WAB1. A total of 14 filers reported holding CARDLYTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$57,252,600
+17.4%
84,195,000
-2.3%
0.01%
+20.0%
Q2 2023$48,755,167
+27.9%
86,195,000
-2.8%
0.01%
+25.0%
Q1 2023$38,125,072
-1.9%
88,700,0000.0%0.01%
-11.1%
Q4 2022$38,855,635
-27.9%
88,700,000
-2.7%
0.01%
-25.0%
Q3 2022$53,927,000
-23.0%
91,200,000
-2.5%
0.01%
-33.3%
Q2 2022$70,038,000
-30.2%
93,500,000
-5.1%
0.02%
-14.3%
Q1 2022$100,325,000
+1.9%
98,500,000
+11.3%
0.02%
+5.0%
Q4 2021$98,497,000
+17.7%
88,500,000
+33.1%
0.02%
+17.6%
Q3 2021$83,651,00066,500,0000.02%
Other shareholders
CARDLYTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
GUARDIAN POINT CAPITAL, LP 5,000,000$5,149,0001.88%
LINDEN ADVISORS LP 65,612,000$66,940,0000.42%
WOLVERINE ASSET MANAGEMENT LLC 38,478,000$39,110,0000.38%
Teton Advisors, Inc. 1,030,000$1,061,0000.18%
683 Capital Management, LLC 2,000,000$2,040,0000.11%
Nicholas Investment Partners, LP 1,385,000$1,401,0000.10%
GABELLI FUNDS LLC 6,920,000$7,128,0000.05%
CAPSTONE INVESTMENT ADVISORS, LLC 10,000,000$10,165,0000.03%
Citadel Advisors 98,500,000$100,325,0000.02%
GAMCO INVESTORS, INC. ET AL 300,000$309,0000.00%
View complete list of CARDLYTICS INC shareholders